Showing results (21-30 of 83) with videos related to

Sort By:
Pageof 9
European Journal of Immunology|November 20, 2019
Glycogen synthetase kinase 3 inhibition drives MIC-A/B to promote cytokine production by human natural killer cells in Dengue virus type 2 infectionCaroline Petitdemange, Christopher Maucourant, Nadine Tarantino, et al.
Plos Pathogens|July 10, 2010
HIV gp41 engages gC1qR on CD4+ T cells to induce the expression of an NK ligand through the PIP3/H2O2 pathwayHugues Fausther-Bovendo, Vincent Vieillard, Sandrine Sagan, et al.
Viruses|April 18, 2018
The Hard Way towards an Antibody-Based HIV-1 Env Vaccine: Lessons from Other VirusesOliver Ringel, Vincent Vieillard, Patrice Debré, et al.
Oncoimmunology|July 23, 2014
Transplantation-induced cancers: Emerging evidence that clonal CMV-specific NK cells are causal immunogenic factorsAbla Achour, Florence Baychelier, Michel Marty, et al.
Blood|August 21, 2013
Identification of a cellular ligand for the natural cytotoxicity receptor NKp44Florence Baychelier, Alexis Sennepin, Myriam Ermonval, et al.
Frontiers in Immunology|May 27, 2014
Control of acute dengue virus infection by natural killer cellsCaroline Petitdemange, Nadia Wauquier, Juliana Rey, et al.
Plos One|September 30, 2014
Association of HLA class-I and inhibitory KIR genotypes in Gabonese patients infected by Chikungunya or Dengue type-2 virusesCaroline Petitdemange, Nadia Wauquier, Jean-Michel Jacquet, et al.
Vaccine|September 20, 2012
An HIVgp41 vaccine protects CD4 central memory T cells in SHIV-infected macaquesVincent Vieillard, Nathalie Dereuddre-Bosquet, Isabelle Mangeot-Méderlé, et al.
AIDS (London, England)|December 22, 2007
NKG2C is a major triggering receptor involved in the V[delta]1 T cell-mediated cytotoxicity against HIV-infected CD4 T cellsHugues Fausther-Bovendo, Nadia Wauquier, Julien Cherfils-Vicini, et al.
Pageof 9